Hi, Shrewd!        Login  
Shrewd'm.com 
A merry & shrewd investing community
 Best Of MacroBest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd
Search
Shrewd'm.com Merry shrewd investors
Search
Best Of MacroBest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd

The week's question
In December 2024, in the thread "Re: BRK: Why Not XOM?", mungofitch asked the members: "As for why the purchases stopped (for a while), perhaps the recent acquisition was seen to be somewhat counter to the capital allocation plans that Mr Buffett thought had been promised?" This week it is put to everyone again. The button below opens the small thread re-asking it - read what others have said so far, then give your own answer as an ordinary reply.
Answer this questionContinue to Shrewd'mThis note won't appear again
Personal Finance / Macroeconomic Trends & Risks
Unthreaded | Threaded | Whole Thread (1) |
Author: PucksFool ✧✺🐝  😊 😞
Number: of 4624 
Subject: Exercise as part of cancer treatment
Date: 10/09/26 7:21 AM
Post New | Post Reply | Report Post | Recommend It!
No. of Recommendations: 3
nytimes.com - Cancer prevention exercise treatment

Lee Colker powered on an iPad in the basement of his Pittsburgh home and logged into a virtual exercise session with Olivia Masten, a trainer who specializes in working with cancer patients.

Mr. Colker, 66, had been dealing with unpredictable fatigue and brain fog since beginning a clinical trial for metastatic kidney cancer this year. When staff at the University of Pittsburgh Medical Center told him an exercise program could improve his energy, he jumped at the opportunity. “That was a clincher for me,” he said.

The program is part of a growing effort around the country to help cancer patients exercise, as the benefits of doing so become increasingly clear.

Observational research has long suggested that exercise improves cancer survival, particularly for breast cancer patients. Last year, a landmark randomized controlled trial showed that colon cancer patients who participated in a structured exercise program with a trainer-coach over three years were less likely to see their cancers come back and had a better quality of life. Among those in the program, 90 percent were alive after eight years, compared with 83 percent in the control group.
A later study showed the program, which altogether cost $3,000 per person, also saved the health system money — “a home run,” said Dr. Scott Ramsey, a cancer researcher and health economist at the Fred Hutch Cancer Center in Washington State.

That combination of benefits is rare among cancer therapies: The new pancreatic cancer drug daraxonrasib, for example, costs $480,000 annually, has unpleasant side effects and, while it prolongs life by several months, does not increase overall long-term survival.

“If we had a drug with this magnitude of benefit, it would immediately become standard of care and funded” by insurance companies, said Dr. Christopher Booth, an oncologist and professor at Queen’s University in Kingston, Ontario, and the leader of the exercise trial.

more at the gift link
Post New | Post Reply | Report Post | Recommend It!
Print the post
Members reply directly to PucksFool here — and replies get answered. Reading is free; so is joining the conversation. Join Shrewd'm »
This community has written 4,615 posts about Macroeconomic Trends & Risks. The article-length ones it recommended most:
AI Tarpits · 36 recs · 2026
End of an era - profit slowdown · 36 recs · 2023
Control Panel: Trend changes in 2026 · 34 recs · 2026
From the Oregon Bay Area (a blogger) · 33 recs · 2025
Lerner Symmetry Theorem · 32 recs · 2025
Unthreaded | Threaded | Whole Thread (1) |


Announcements
Macroeconomic Trends & Risks FAQ
Contact Shrewd'm
Contact the developer of these message boards.

Ticker or Board Name Author

Best Of Macro | Best Of | Favourites & Replies | All Boards | Followed Shrewds | Open Questions | Moving a community